标题
Predictive biomarkers in gastric cancer
作者
关键词
-
出版物
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-10-19
DOI
10.1007/s00432-022-04408-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses
- (2022) Hiroyuki Matsubayashi et al. BMC CANCER
- Current status and future perspectives in HER2 positive advanced gastric cancer
- (2022) G. Roviello et al. Clinical & Translational Oncology
- FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort
- (2022) Thorben Schrumpf et al. PLoS One
- FAST: A randomised phase II study of zolbetuximab (IMAB362) plus EOX vs EOX alone for first-line treatment of advanced CLDN18.2 positive gastric and gastro-oesophageal adenocarcinoma
- (2021) U. Sahin et al. ANNALS OF ONCOLOGY
- Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell Density
- (2021) Dita Ulase et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis
- (2021) Rouven Hoefflin et al. Cancers
- Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials
- (2021) F. Pietrantonio et al. ESMO Open
- Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
- (2021) Li Zhang et al. Diagnostic Pathology
- Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma
- (2021) Alexander Quaas et al. Gastric Cancer
- HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study
- (2021) Ivonne Haffner et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy
- (2021) Soomin Ahn et al. MODERN PATHOLOGY
- Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
- (2021) Yoshiaki Nakamura et al. Nature Reviews Clinical Oncology
- Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
- (2021) Ronan J. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration
- (2021) Akira Ooki et al. Gastric Cancer
- Landscape of EBV-positive gastric cancer
- (2021) Motonobu Saito et al. Gastric Cancer
- Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
- (2021) Jong-Mu Sun et al. LANCET
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score
- (2021) Yoon Ah Cho et al. Cancers
- Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center
- (2021) Alexander Quaas et al. Frontiers in Oncology
- Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer
- (2021) Aurelia Noske et al. BREAST
- The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
- (2021) Nadia Bolandi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
- (2021) Christoph Röcken et al. Genome Medicine
- The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis
- (2021) Wen-Long Guan et al. Frontiers in Oncology
- PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer
- (2021) Yukiya Narita et al. Journal of Gastrointestinal Oncology
- Sex and Gender Aspects for Patient Stratification in Allergy Prevention and Treatment
- (2020) Massimo De Martinis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers
- (2020) Joon Young Hur et al. PATHOLOGY RESEARCH AND PRACTICE
- Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
- (2020) Katharina von Loga et al. Nature Communications
- Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
- (2020) Shenghua Zhan et al. Frontiers in Oncology
- Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies
- (2020) Valeska Moentenich et al. Oncology Letters
- Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
- (2020) A. Arnold et al. Clinical & Translational Oncology
- Sex and Gender Influences on Cancer Immunotherapy Response
- (2020) Azzurra Irelli et al. Biomedicines
- A multicentre analytical comparison study of inter‐reader and inter‐assay agreement of four programmed death‐ligand 1 (PD‐L1) immunohistochemistry assays for scoring in triple‐negative breast cancer
- (2020) Aurelia Noske et al. HISTOPATHOLOGY
- Gastric cancer
- (2020) Elizabeth C Smyth et al. LANCET
- Sex and gender: modifiers of health, disease, and medicine
- (2020) Franck Mauvais-Jarvis et al. LANCET
- The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma
- (2019) Heike Loeser et al. OncoImmunology
- Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis
- (2019) Lingchuan Guo et al. MEDICINE
- Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
- (2019) Filippo Pietrantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women
- (2019) Franziska Clausen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Therapy Resistance in Neoadjuvantly Treated Gastric Cancer and Cancer of the Gastroesophageal Junction is Associated with an Increased Expression of Immune Checkpoint Inhibitors—Comparison Against a Therapy Naïve Cohort
- (2019) Hauke Schoop et al. Translational Oncology
- S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL
- (2019) Markus Moehler et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non–Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs
- (2018) Enrico Munari et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis
- (2018) Arnaldo N. S. Silva et al. ANNALS OF SURGERY
- Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
- (2018) Takeru Wakatsuki et al. JOURNAL OF GASTROENTEROLOGY
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Mutation heterogeneity between primary gastric cancers and their matched lymph node metastases
- (2018) Han Hong Lee et al. Gastric Cancer
- VSIG-3 as a ligand of VISTA inhibits human T cell function
- (2018) Jinghua Wang et al. IMMUNOLOGY
- Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
- (2018) Shusuke Yagi et al. Gastric Cancer
- Menopausal hormone therapy and the risk of esophageal and gastric cancer
- (2017) Nele Brusselaers et al. INTERNATIONAL JOURNAL OF CANCER
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer
- (2017) Mikito Inokuchi et al. World Journal of Surgical Oncology
- Prognostic relevance of FGFR2 expression in stage�II/III gastric cancer with curative resection and S‑1 chemotherapy
- (2017) Kei Hosoda et al. Oncology Letters
- A molecular portrait of microsatellite instability across multiple cancers
- (2017) Isidro Cortes-Ciriano et al. Nature Communications
- Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
- (2017) Eirini Pectasides et al. Cancer Discovery
- Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited
- (2017) Micaela Mathiak et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Chromosomal Instability in Gastric Cancer Biology
- (2017) Saffiyeh Saboor Maleki et al. NEOPLASIA
- The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
- (2017) Christine Böger et al. OncoImmunology
- Mismatch Repair Deficiency, Microsatellite Instability, and Survival
- (2017) Elizabeth C. Smyth et al. JAMA Oncology
- Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant
- (2016) Jun Li et al. AMERICAN JOURNAL OF HUMAN GENETICS
- HER2Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
- (2016) Angela N. Bartley et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma
- (2016) Raul S. Gonzalez et al. HUMAN PATHOLOGY
- A protein and mRNA expression-based classification of gastric cancer
- (2016) Namrata Setia et al. MODERN PATHOLOGY
- FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival
- (2016) Soomin Ahn et al. MODERN PATHOLOGY
- Limits to Personalized Cancer Medicine
- (2016) Ian F. Tannock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma
- (2016) Yuta Kondo et al. ORAL ONCOLOGY
- HER2-Testung beim Magenkarzinom
- (2016) G. Baretton et al. PATHOLOGE
- Genetic predisposition to gastric cancer
- (2016) Iva Petrovchich et al. SEMINARS IN ONCOLOGY
- Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers
- (2016) Seyoung Seo et al. Oncotarget
- Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm
- (2016) Cheol Keun Park et al. Oncotarget
- PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
- (2016) Christine Böger et al. Oncotarget
- Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma
- (2016) Ryuma Tokunaga et al. Oncotarget
- Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis
- (2015) Xuechao Liu et al. BMC CANCER
- Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer
- (2015) Iikki Donner et al. Familial Cancer
- MET in gastric cancer - discarding a 10% cutoff rule
- (2015) Marie-Luise Metzger et al. HISTOPATHOLOGY
- Sex-Driven Differences in Immunological Responses: Challenges and Opportunities for the Immunotherapies of the Third Millennium
- (2015) Leonardo Mirandola et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germlineCDH1mutation carriers
- (2015) Rachel S van der Post et al. JOURNAL OF MEDICAL GENETICS
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development
- (2015) Stephen P. Hack et al. Oncotarget
- MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
- (2015) Denis L. Fontes Jardim et al. Oncotarget
- FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
- (2014) X Su et al. BRITISH JOURNAL OF CANCER
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Pembrolizumab: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma
- (2014) Akiko Kawano Nagatsuma et al. Gastric Cancer
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
- (2014) Miwako Kakiuchi et al. NATURE GENETICS
- Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
- (2014) Kai Wang et al. NATURE GENETICS
- Helicobacter pylori: perspectives and time trends
- (2014) Peter Malfertheiner et al. Nature Reviews Gastroenterology & Hepatology
- Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine
- (2013) Viktoria S. Warneke et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- cMET as a potential therapeutic target in gastric cancer (Review)
- (2013) LISONG TENG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer
- (2013) Yoon-Koo Kang et al. INVESTIGATIONAL NEW DRUGS
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- (2013) Manish A. Shah et al. PLoS One
- Down-Regulation of Claudin-18 Is Associated with the Proliferative and Invasive Potential of Gastric Cancer at the Invasive Front
- (2013) Tadayuki Oshima et al. PLoS One
- SeXX matters in immunity
- (2013) J.G. Markle et al. TRENDS IN IMMUNOLOGY
- FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation
- (2013) Guy Betts et al. VIRCHOWS ARCHIV
- MET: A Critical Player in Tumorigenesis and Therapeutic Target
- (2013) C. R. Graveel et al. Cold Spring Harbor Perspectives in Biology
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- FGFR2 gene amplification and clinicopathological features in gastric cancer
- (2012) K Matsumoto et al. BRITISH JOURNAL OF CANCER
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma
- (2012) Eun-Jung Jung et al. HUMAN PATHOLOGY
- An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer
- (2012) Ian J Majewski et al. JOURNAL OF PATHOLOGY
- HER2 testing in gastric cancer: a practical approach
- (2012) Josef Rüschoff et al. MODERN PATHOLOGY
- Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization
- (2012) Shin-ichiro Kiyose et al. PATHOLOGY INTERNATIONAL
- Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue
- (2012) M. Tevfik Dorak et al. Frontiers in Genetics
- RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
- (2011) Daniel V.T. Catenacci et al. CANCER BIOLOGY & THERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome
- (2011) D L Worthley et al. GUT
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Epstein-Barr virus-associated gastric carcinoma
- (2011) Masashi Fukayama et al. PATHOLOGY RESEARCH AND PRACTICE
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Sex bias in neuroscience and biomedical research
- (2010) Annaliese K. Beery et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Sex Disparities in Cancer Incidence by Period and Age
- (2009) M. B. Cook et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
- (2008) U. Sahin et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started